Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Aerovate Therapeutics, Inc. (AVTE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
23 Feb 2024
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,251
-13%
511
$19.50
$9,964.50
SELL
20 Feb 2024
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
4,149
-45%
3,489
$20.23
$70,574.50
SELL
5 Feb 2024
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,609
-74%
4,600
$17.45
$80,249.30
SELL
17 Jan 2024
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,251
-55%
4,000
$19.50
$78,000.00
SELL
5 Jan 2024
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
4,083
-52%
4,600
$19.16
$88,115.82
SELL
27 Dec 2023
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,251
-3%
125
$24.50
$3,062.50
SELL
20 Dec 2023
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,251
-55%
4,000
$19.50
$78,000.00
SELL
13 Dec 2023
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,251
-78%
12,000
$19.50
$234,000.00
SELL
1 Nov 2023
Verwijs Marinus
CHIEF TECHNOLOGY OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
970
$10.46
$10,148.63
SELL
1 Nov 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
1,092
$10.42
$11,378.64
SELL
6 Sep 2023
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,291
-75%
3,961
$15.06
$59,637.01
SELL
7 Aug 2023
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,832
-84%
10,283
$15.52
$159,580.14
SELL
28 Jul 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
5,478
$18.00
$98,604.00
SELL
6 Jul 2023
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,291
-88%
10,283
$16.66
$171,283.92
SELL
5 Jul 2023
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,828
-55%
2,250
$17.30
$38,914.87
SELL
3 Jul 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
10,000
$18.00
$180,000.00
SELL
6 Jun 2023
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,306
-88%
10,283
$16.28
$167,415.61
SELL
5 Jun 2023
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,609
-58%
2,250
$16.26
$36,576.00
SELL
19 May 2023
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,251
-1%
65
$19.50
$1,267.50
SELL
17 May 2023
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,251
-25%
1,090
$19.59
$21,355.83
SELL
3 May 2023
Verwijs Marinus
SENIOR VICE PRESIDENT, CMC, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
759
$20.79
$15,779.38
SELL
1 May 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
15,693
$20.63
$323,745.44
SELL
21 Apr 2023
Gillies Hunter
CHIEF MEDICAL OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,960
-67%
4,000
$19.50
$78,000.00
SELL
6 Apr 2023
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
10,283
$18.17
$186,828.73
SELL
5 Apr 2023
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
2,144
-51%
2,250
$18.20
$40,942.29
SELL
3 Apr 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
5,828
-72%
15,000
$19.39
$290,916.22
SELL
1 Mar 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
9,038
-62%
15,000
$23.81
$357,196.30
SELL
6 Feb 2023
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,426
-87%
10,284
$24.59
$252,881.25
SELL
6 Feb 2023
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,609
-58%
2,250
$24.27
$54,612.00
SELL
1 Feb 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
4,495
-76%
15,000
$22.68
$340,196.90
SELL
6 Jan 2023
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
2,792
-78%
10,284
$25.98
$267,202.70
SELL
5 Jan 2023
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,609
-58%
2,250
$26.40
$59,404.50
SELL
3 Jan 2023
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,073
-82%
15,000
$27.07
$406,076.12
SELL
12 Dec 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
2,039
-50%
2,059
$29.43
$60,591.48
SELL
9 Dec 2022
Eldridge George A
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,960
-87%
13,969
$28.43
$397,193.30
SELL
8 Dec 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
10,394
$22.74
$236,309.61
SELL
7 Dec 2022
Eldridge George A
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
13,011
-64%
23,648
$21.85
$516,782.38
SELL
6 Dec 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
37,989
-51%
40,000
$17.67
$706,772.44
SELL
5 Dec 2022
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,609
-58%
2,250
$17.38
$39,114.00
SELL
1 Dec 2022
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
15,000
$18.00
$270,000.00
SELL
30 Nov 2022
Eldridge George A
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,960
-4%
85
$19.06
$1,620.13
SELL
18 Nov 2022
Eldridge George A
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,960
-34%
1,037
$19.43
$20,151.12
SELL
9 Nov 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,746
-92%
21,998
$18.87
$415,084.94
SELL
7 Nov 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
26,000
$18.24
$474,351.34
SELL
7 Nov 2022
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,409
-39%
2,250
$19.20
$43,194.40
SELL
2 Nov 2022
Verwijs Marinus
SENIOR VICE PRESIDENT, CMC, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
1,130
$18.89
$21,345.70
SELL
1 Nov 2022
NOYES TIMOTHY P
CHIEF EXECUTIVE OFFICER, Director, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
1,038
$19.50
$20,241.00
SELL
18 Oct 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
5,705
$21.08
$120,286.50
SELL
14 Oct 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
0
-100%
4,295
$20.16
$86,585.14
SELL
10 Oct 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,430
-77%
4,954
$16.89
$83,681.06
SELL
6 Oct 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,757
-93%
23,560
$15.91
$374,803.40
SELL
5 Oct 2022
NIVEN RALPH
CHIEF SCIENTIFIC OFFICER, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,800
-55%
2,250
$15.75
$35,446.59
SELL
12 Sep 2022
Dake Benjamin T
SEE REMARKS, Officer
Aerovate Therapeutics, Inc.
(AVTE)
2,248
-76%
7,520
$17.33
$130,306.52
SELL
8 Sep 2022
Dake Benjamin T
See Remarks, Officer
Aerovate Therapeutics, Inc.
(AVTE)
176
-97%
7,840
$17.80
$139,584.30
SELL
6 Sep 2022
NIVEN RALPH
Chief Scientific Officer, Officer
Aerovate Therapeutics, Inc.
(AVTE)
1,609
-58%
2,250
$19.00
$42,750.00
SELL
6 Sep 2022
Dake Benjamin T
See Remarks, Officer
Aerovate Therapeutics, Inc.
(AVTE)
3,658
-77%
12,828.562
$18.50
$237,344.78
SELL
16 Aug 2022
Dake Benjamin T
See Remarks, Officer
Aerovate Therapeutics, Inc.
(AVTE)
10,525
-66%
21,000
$23.00
$482,931.90
SELL
10 Aug 2022
Dake Benjamin T
See Remarks, Officer
Aerovate Therapeutics, Inc.
(AVTE)
79
-99%
14,067
$24.07
$338,598.25
SELL
8 Aug 2022
Dake Benjamin T
See Remarks, Officer
Aerovate Therapeutics, Inc.
(AVTE)
2,791
-84%
15,643
$24.31
$380,287.00
BUY
2 Jul 2021
RA CAPITAL MANAGEMENT, L.P.
Director, 10% Owner
Aerovate Therapeutics, Inc.
(AVTE)
6,965,568
+66%
2,785,714
$14.00
$38,999,996.00
BUY
2 Jul 2021
Atlas Venture Fund XII, L.P.
10% Owner
Aerovate Therapeutics, Inc.
(AVTE)
3,103,879
+20%
535,714
$14.00
$7,499,996.00
BUY
2 Jul 2021
Sofinnova Venture Partners X, L.P.
10% Owner
Aerovate Therapeutics, Inc.
(AVTE)
3,758,686
+10%
357,142
$14.00
$4,999,988.00
BUY
2 Jul 2021
Cormorant Asset Management, LP
Former 10% Owner
Aerovate Therapeutics, Inc.
(AVTE)
2,030,691
+32%
500,000
$14.00
$7,000,000.00
BUY
1 Jul 2021
GRAYZEL DAVID S.
Director
Aerovate Therapeutics, Inc.
(AVTE)
3,103,879
+20%
535,714
$14.00
$7,499,996.00
BUY
1 Jul 2021
Katabi Maha
Director, 10% Owner
Aerovate Therapeutics, Inc.
(AVTE)
3,758,686
+10%
357,142
$14.00
$4,999,988.00
Home